Response to General revision of Commission Regulation (EU) No 651/2014 of 17 June 2014 declaring certain categories of aid compatible with the internal market in application of Articles 107 and 108 of the Treaty (‘General Block Exemption Regulation’)

6 Oct 2025

Response to Proposal for a REGULATION OF THE EUROPEAN PARLIAMENT AND OF THE COUNCIL laying a framework for strengthening the availability and security of supply of critical medicinal products as well as the availability of, and accessibility of, medicinal products of common interest, and amending Regulation (EU) 2024/795

5 May 2025

Response to Critical Medicines Act

24 Feb 2025

Meeting with Adam Jarubas (Member of the European Parliament) and The Employers' Union of Innovative Pharmaceutical Companies

15 Mar 2024 · Pharmaceutical Package

Response to Report on the review of the implementation of the operations of the Health Emergency Preparedness and Response Authority (HERA) pursuant article 8 of the Commission decision c(2021) 6712 of 16 September establishing HERA.

16 Feb 2024

Meeting with Adam Jarubas (Member of the European Parliament)

4 Dec 2023 · Access to medicines in the EU

Response to Proposal for a DIRECTIVE OF THE EUROPEAN PARLIAMENT AND OF THE COUNCIL on the Union code relating to medicinal products for human use, and repealing Directive 2001/83/EC and Directive 2009/35/EC

31 Oct 2023

Response to Proposal for a REGULATION OF THE EUROPEAN PARLIAMENT AND OF THE COUNCIL laying down Union procedures for the authorisation and supervision of medicinal products for human use and establishing rules governing the European Medicines Agency, amending Regulation (EC) No 1394/2007 and Regulation (EU) No 536/2014 and repealing Regulation (EC) No 726/2004, Regulation (EC) No 141/2000 and Regulation (EC) No 1901/2006

31 Oct 2023

Response to Commission Communication on a new European Innovation Agenda

9 May 2022

Response to Single Market Emergency Instrument (SMEI)

9 May 2022

Response to Proposal for a Regulation amending Regulations (EC) No 469/2009 and 1610/96 concerning supplementary protection certificates (SPCs) with a view to creating a unified granting procedure, and proposal for a Regulation creating a unitary SPC

1 Apr 2022

Response to Evaluation and Revision of Regulation (EC) No 726/2004 and Directive 2001/83/EC

26 Apr 2021

Response to Proposal for a REGULATION OF THE EUROPEAN PARLIAMENT AND OF THE COUNCIL on serious cross-border threats to health and repealing Decision No 1082/2013/EU

2 Feb 2021

Response to Proposal for a REGULATION OF THE EUROPEAN PARLIAMENT AND OF THE COUNCIL amending Regulation (EC) No 851/2004 establishing a European Centre for disease prevention and control

2 Feb 2021

Response to Proposal for a REGULATION OF THE EUROPEAN PARLIAMENT AND OF THE COUNCIL on a reinforced role for the European Medicines Agency in crisis preparedness and management for medicinal products and medical devices

2 Feb 2021

Response to Communication from the Commission to the European Parliament, the Council, the European Economic and Social Committee and the Committee of the Regions "Making the most of EU’s innovative potential - An Intellectual Property action plan in support of the EU’s industrial competitiveness"

6 Aug 2020

Response to Commission Communication on a Pharmaceutical Strategy- Ensuring sustainable innovation and the availability and affordability of medicines and medical technologies for citizens

1 Jul 2020